A bird-flu pandemic in people? Here’s what it might look like Penn In the News The New York Times A bird-flu pandemic in people? Here’s what it might look like Scott Hensley of the Perelman School of Medicine says that the bird flu virus would have to change significantly to be able to bind effectively to human cells. New ‘armored’ CAR therapy produces significant responses in cancer patients Image: iStock/tiratus phaesuwan New ‘armored’ CAR therapy produces significant responses in cancer patients For patients whose cancers don't respond to current CAR T cell therapies, a new, modified CAR T cell therapy by Penn’s Carl June shows promise in a phase 1 clinical trial. Disease from parasite in U.S. water supply might finally be treatable Penn In the News Newsweek Disease from parasite in U.S. water supply might finally be treatable A paper by Katelyn A. Walzer and Boris Striepen of the School of Veterinary Medicine reveals the gene expression of the parasite cryptosporidium across its life cycle. mRNA vaccine by UPenn scientists could manage bird flu outbreak Penn In the News The Hill mRNA vaccine by UPenn scientists could manage bird flu outbreak Researchers led by Scott Hensley of the Perelman School of Medicine have collaborated with Drew Weissman to develop an mRNA vaccine to treat the H5N1 avian flu. Penn Medicine creates human bird flu vaccine Penn In the News 6ABC.com Penn Medicine creates human bird flu vaccine Researchers at Penn Medicine have created a human bird flu vaccine using mRNA, the same platform as the COVID-19 vaccine. Researchers are working on a new mRNA vaccine—this time for bird flu Penn In the News Fast Company Researchers are working on a new mRNA vaccine—this time for bird flu Researchers led by Scott Hensley of the Perelman School of Medicine are developing an mRNA vaccine for the H5N1 avian flu with support from Nobel Prize cowinner Drew Weissman. Honoring a life scientist’s lifesaving science nocred Honoring a life scientist’s lifesaving science Carl June accepted the 2024 Breakthrough Prize in Life Sciences at a Los Angeles ceremony, making him the sixth recipient from Penn. Study reveals inequities in access to transformative CAR T cell therapy Image: iStock/PeopleImages Study reveals inequities in access to transformative CAR T cell therapy Penn Medicine researchers have assessed the percentage of patients from minority health populations and reveal inequities in access to transformative CAR T cell therapy. Accelerating CAR T cell therapy: Lipid nanoparticles speed up manufacturing Image: iStock/Love Employee Accelerating CAR T cell therapy: Lipid nanoparticles speed up manufacturing Penn Engineers have developed a novel method for manufacturing CAR T cells using lipid nanoparticles as delivery vehicles. Initial SARS-CoV-2 vaccinations prime immune cells to respond to subsequent variants Image: iStock/Thicha Satapitanon Initial SARS-CoV-2 vaccinations prime immune cells to respond to subsequent variants Immunological imprinting from the original ancestral SARS-CoV-2 strain has a significant impact on the antibody responses to the variants and boosters based on them. Load More
New ‘armored’ CAR therapy produces significant responses in cancer patients Image: iStock/tiratus phaesuwan New ‘armored’ CAR therapy produces significant responses in cancer patients For patients whose cancers don't respond to current CAR T cell therapies, a new, modified CAR T cell therapy by Penn’s Carl June shows promise in a phase 1 clinical trial.
Disease from parasite in U.S. water supply might finally be treatable Penn In the News Newsweek Disease from parasite in U.S. water supply might finally be treatable A paper by Katelyn A. Walzer and Boris Striepen of the School of Veterinary Medicine reveals the gene expression of the parasite cryptosporidium across its life cycle. mRNA vaccine by UPenn scientists could manage bird flu outbreak Penn In the News The Hill mRNA vaccine by UPenn scientists could manage bird flu outbreak Researchers led by Scott Hensley of the Perelman School of Medicine have collaborated with Drew Weissman to develop an mRNA vaccine to treat the H5N1 avian flu. Penn Medicine creates human bird flu vaccine Penn In the News 6ABC.com Penn Medicine creates human bird flu vaccine Researchers at Penn Medicine have created a human bird flu vaccine using mRNA, the same platform as the COVID-19 vaccine. Researchers are working on a new mRNA vaccine—this time for bird flu Penn In the News Fast Company Researchers are working on a new mRNA vaccine—this time for bird flu Researchers led by Scott Hensley of the Perelman School of Medicine are developing an mRNA vaccine for the H5N1 avian flu with support from Nobel Prize cowinner Drew Weissman. Honoring a life scientist’s lifesaving science nocred Honoring a life scientist’s lifesaving science Carl June accepted the 2024 Breakthrough Prize in Life Sciences at a Los Angeles ceremony, making him the sixth recipient from Penn. Study reveals inequities in access to transformative CAR T cell therapy Image: iStock/PeopleImages Study reveals inequities in access to transformative CAR T cell therapy Penn Medicine researchers have assessed the percentage of patients from minority health populations and reveal inequities in access to transformative CAR T cell therapy. Accelerating CAR T cell therapy: Lipid nanoparticles speed up manufacturing Image: iStock/Love Employee Accelerating CAR T cell therapy: Lipid nanoparticles speed up manufacturing Penn Engineers have developed a novel method for manufacturing CAR T cells using lipid nanoparticles as delivery vehicles. Initial SARS-CoV-2 vaccinations prime immune cells to respond to subsequent variants Image: iStock/Thicha Satapitanon Initial SARS-CoV-2 vaccinations prime immune cells to respond to subsequent variants Immunological imprinting from the original ancestral SARS-CoV-2 strain has a significant impact on the antibody responses to the variants and boosters based on them. Load More
mRNA vaccine by UPenn scientists could manage bird flu outbreak Penn In the News The Hill mRNA vaccine by UPenn scientists could manage bird flu outbreak Researchers led by Scott Hensley of the Perelman School of Medicine have collaborated with Drew Weissman to develop an mRNA vaccine to treat the H5N1 avian flu. Penn Medicine creates human bird flu vaccine Penn In the News 6ABC.com Penn Medicine creates human bird flu vaccine Researchers at Penn Medicine have created a human bird flu vaccine using mRNA, the same platform as the COVID-19 vaccine. Researchers are working on a new mRNA vaccine—this time for bird flu Penn In the News Fast Company Researchers are working on a new mRNA vaccine—this time for bird flu Researchers led by Scott Hensley of the Perelman School of Medicine are developing an mRNA vaccine for the H5N1 avian flu with support from Nobel Prize cowinner Drew Weissman. Honoring a life scientist’s lifesaving science nocred Honoring a life scientist’s lifesaving science Carl June accepted the 2024 Breakthrough Prize in Life Sciences at a Los Angeles ceremony, making him the sixth recipient from Penn. Study reveals inequities in access to transformative CAR T cell therapy Image: iStock/PeopleImages Study reveals inequities in access to transformative CAR T cell therapy Penn Medicine researchers have assessed the percentage of patients from minority health populations and reveal inequities in access to transformative CAR T cell therapy. Accelerating CAR T cell therapy: Lipid nanoparticles speed up manufacturing Image: iStock/Love Employee Accelerating CAR T cell therapy: Lipid nanoparticles speed up manufacturing Penn Engineers have developed a novel method for manufacturing CAR T cells using lipid nanoparticles as delivery vehicles. Initial SARS-CoV-2 vaccinations prime immune cells to respond to subsequent variants Image: iStock/Thicha Satapitanon Initial SARS-CoV-2 vaccinations prime immune cells to respond to subsequent variants Immunological imprinting from the original ancestral SARS-CoV-2 strain has a significant impact on the antibody responses to the variants and boosters based on them. Load More
Penn Medicine creates human bird flu vaccine Penn In the News 6ABC.com Penn Medicine creates human bird flu vaccine Researchers at Penn Medicine have created a human bird flu vaccine using mRNA, the same platform as the COVID-19 vaccine. Researchers are working on a new mRNA vaccine—this time for bird flu Penn In the News Fast Company Researchers are working on a new mRNA vaccine—this time for bird flu Researchers led by Scott Hensley of the Perelman School of Medicine are developing an mRNA vaccine for the H5N1 avian flu with support from Nobel Prize cowinner Drew Weissman. Honoring a life scientist’s lifesaving science nocred Honoring a life scientist’s lifesaving science Carl June accepted the 2024 Breakthrough Prize in Life Sciences at a Los Angeles ceremony, making him the sixth recipient from Penn. Study reveals inequities in access to transformative CAR T cell therapy Image: iStock/PeopleImages Study reveals inequities in access to transformative CAR T cell therapy Penn Medicine researchers have assessed the percentage of patients from minority health populations and reveal inequities in access to transformative CAR T cell therapy. Accelerating CAR T cell therapy: Lipid nanoparticles speed up manufacturing Image: iStock/Love Employee Accelerating CAR T cell therapy: Lipid nanoparticles speed up manufacturing Penn Engineers have developed a novel method for manufacturing CAR T cells using lipid nanoparticles as delivery vehicles. Initial SARS-CoV-2 vaccinations prime immune cells to respond to subsequent variants Image: iStock/Thicha Satapitanon Initial SARS-CoV-2 vaccinations prime immune cells to respond to subsequent variants Immunological imprinting from the original ancestral SARS-CoV-2 strain has a significant impact on the antibody responses to the variants and boosters based on them. Load More
Researchers are working on a new mRNA vaccine—this time for bird flu Penn In the News Fast Company Researchers are working on a new mRNA vaccine—this time for bird flu Researchers led by Scott Hensley of the Perelman School of Medicine are developing an mRNA vaccine for the H5N1 avian flu with support from Nobel Prize cowinner Drew Weissman. Honoring a life scientist’s lifesaving science nocred Honoring a life scientist’s lifesaving science Carl June accepted the 2024 Breakthrough Prize in Life Sciences at a Los Angeles ceremony, making him the sixth recipient from Penn. Study reveals inequities in access to transformative CAR T cell therapy Image: iStock/PeopleImages Study reveals inequities in access to transformative CAR T cell therapy Penn Medicine researchers have assessed the percentage of patients from minority health populations and reveal inequities in access to transformative CAR T cell therapy. Accelerating CAR T cell therapy: Lipid nanoparticles speed up manufacturing Image: iStock/Love Employee Accelerating CAR T cell therapy: Lipid nanoparticles speed up manufacturing Penn Engineers have developed a novel method for manufacturing CAR T cells using lipid nanoparticles as delivery vehicles. Initial SARS-CoV-2 vaccinations prime immune cells to respond to subsequent variants Image: iStock/Thicha Satapitanon Initial SARS-CoV-2 vaccinations prime immune cells to respond to subsequent variants Immunological imprinting from the original ancestral SARS-CoV-2 strain has a significant impact on the antibody responses to the variants and boosters based on them.
Honoring a life scientist’s lifesaving science nocred Honoring a life scientist’s lifesaving science Carl June accepted the 2024 Breakthrough Prize in Life Sciences at a Los Angeles ceremony, making him the sixth recipient from Penn.
Study reveals inequities in access to transformative CAR T cell therapy Image: iStock/PeopleImages Study reveals inequities in access to transformative CAR T cell therapy Penn Medicine researchers have assessed the percentage of patients from minority health populations and reveal inequities in access to transformative CAR T cell therapy.
Accelerating CAR T cell therapy: Lipid nanoparticles speed up manufacturing Image: iStock/Love Employee Accelerating CAR T cell therapy: Lipid nanoparticles speed up manufacturing Penn Engineers have developed a novel method for manufacturing CAR T cells using lipid nanoparticles as delivery vehicles.
Initial SARS-CoV-2 vaccinations prime immune cells to respond to subsequent variants Image: iStock/Thicha Satapitanon Initial SARS-CoV-2 vaccinations prime immune cells to respond to subsequent variants Immunological imprinting from the original ancestral SARS-CoV-2 strain has a significant impact on the antibody responses to the variants and boosters based on them.